.
MergerLinks Header Logo

New Deal


Announced

Completed

KKR acquired LCY Chemical Corp for $1.56bn.

Financials

Edit Data
Transaction Value£1,187m
Consideration TypeCash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Taiwan

Pharmaceuticals

Public

Acquisition

pharmaceutical company

Completed

Private Equity

Synopsis

Edit

KKR acquired LCY Chemical Corp, a chemical company which manufactures and sells petrochemicals primarily in Taiwan, for $1.56bn or TWD 56 per share in cash. The offer price represents a premium of 17.28% to LCY's closing price on 20 July 2018. Mr. TH Hong, Chairman of LCY, said, "The proposed transaction delivers meaningful and immediate value to our shareholders, while also providing greater access to capital, operational resources and the time horizon needed to execute a strategy to drive long-term, sustainable value creation. KKR is the ideal partner to help us build on our 50-year track record of producing high-quality chemical products for customers worldwide and take LCY to its next level of growth given KKR's focus on responsible business and operational excellence. KKR's decision to partner with us is a testament to the innovative and talented team we have built in Taiwan - and around the world - and we look forward to working with them to build an even stronger company."

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US